JAMES H WELCH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES H WELCH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES H WELCH. JAMES H WELCH is a CFO, VP & Secretary in RIGEL PHARMACEUTICALS INC ($RIGL) and a Chief Financial Officer in Eiger BioPharmaceuticals, Inc. ($EIGR) and a See Remarks in ADURO BIOTECH, INC. ($ADRO).
Address: 1180 VETERANS BLVD. SOUTH SAN FRANCISCO 94080 CA
Companies in which JAMES H WELCH is an Insider
CHINOOK THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JAMES H WELCH: See Remarks
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 15 2019
$ADRO Market Capitalization: $745.72M
$ADRO Previous Close: $11.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Eiger BioPharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JAMES H WELCH: Chief Financial Officer
Holdings: 2,500 shares
Current Value: $29,000
Latest Transaction: Mar 16 2018
$EIGR Market Capitalization: $93.59M
$EIGR Previous Close: $11.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RIGEL PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JAMES H WELCH: CFO, VP & Secretary
Holdings: 3,757 shares
Current Value: $9,205
Latest Transaction: Sep 03 2004
$RIGL Market Capitalization: $237.45M
$RIGL Previous Close: $2.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JAMES H WELCH
Sentiment: All, ADRO, EIGR, RIGL
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 15 2019 | ADRO | ADURO BIOTECH, INC ... | WELCH JAMES H | See Remarks | Option Exercise | A | 1.52 | 200,000 | 304,000 | 200,000 | |
| Mar 16 2018 | EIGR | Eiger BioPharmaceu ... | WELCH JAMES H | Chief Financial Off ... | Option Exercise | A | 9.50 | 60,000 | 570,000 | 60,000 | |
| Mar 14 2017 | EIGR | Eiger BioPharmaceu ... | WELCH JAMES H | Chief Financial Off ... | Option Exercise | A | 11.75 | 40,000 | 470,000 | 40,000 | |
| Jun 22 2016 | EIGR | Eiger BioPharmaceu ... | WELCH JAMES H | Chief Financial Off ... | Buy | P | 19.79 | 500 | 9,897 | 2,500 | 2 K to 2.5 K (+25.00 %) |
| Jun 22 2016 | EIGR | Eiger BioPharmaceu ... | WELCH JAMES H | Chief Financial Off ... | Buy | P | 19.80 | 2,000 | 39,592 | 2,000 | 0 to 2 K |
| Mar 28 2016 | EIGR | Eiger BioPharmaceu ... | WELCH JAMES H | Chief Financial Off ... | Option Exercise | A | 15.89 | 57,571 | 914,803 | 57,571 | |
| Sep 03 2004 | RIGL | RIGEL PHARMACEUTIC ... | WELCH JAMES H | CFO, VP & Secretary | Option Exercise | M | 1.80 | 5,500 | 9,900 | 7,000 |